Arrow Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $322K | Sell |
11,476
-270
| -2% | -$7.19K | 0.03% | 140 |
|
|
2025
Q4 | $292K | Sell |
11,746
-247
| -2% | -$6.23K | 0.03% | 140 |
|
|
2025
Q3 | $306K | Sell |
11,993
-213
| -2% | -$5.26K | 0.03% | 135 |
|
|
2025
Q2 | $296K | Buy |
12,206
+16
| +0.1% | +$373 | 0.03% | 142 |
|
|
2025
Q1 | $309K | Sell |
12,190
-180
| -1% | -$4.71K | 0.03% | 138 |
|
|
2024
Q4 | $328K | Sell |
12,370
-1,173
| -9% | -$31.8K | 0.03% | 148 |
|
|
2024
Q3 | $392K | Sell |
13,543
-3,091
| -19% | -$90.2K | 0.04% | 143 |
|
|
2024
Q2 | $465K | Sell |
16,634
-5,185
| -24% | -$143K | 0.05% | 133 |
|
|
2024
Q1 | $605K | Sell |
21,819
-21,121
| -49% | -$586K | 0.06% | 122 |
|
|
2023
Q4 | $1.24M | Sell |
42,940
-40,673
| -49% | -$1.23M | 0.13% | 95 |
|
|
2023
Q3 | $2.77M | Sell |
83,613
-23,616
| -22% | -$835K | 0.33% | 65 |
|
|
2023
Q2 | $3.93M | Sell |
107,229
-2,782
| -3% | -$108K | 0.47% | 53 |
|
|
2023
Q1 | $4.49M | Sell |
110,011
-10,131
| -8% | -$438K | 0.59% | 47 |
|
|
2022
Q4 | $6.16M | Sell |
120,142
-794
| -0.7% | -$38.1K | 0.84% | 28 |
|
|
2022
Q3 | $5.29M | Sell |
120,936
-1,301
| -1% | -$63.2K | 0.77% | 30 |
|
|
2022
Q2 | $6.41M | Sell |
122,237
-1,625
| -1% | -$82.8K | 0.87% | 26 |
|
|
2022
Q1 | $6.41M | Sell |
123,862
-1,169
| -0.9% | -$60.7K | 0.77% | 26 |
|
|
2021
Q4 | $7.38M | Sell |
125,031
-2,141
| -2% | -$106K | 0.87% | 23 |
|
|
2021
Q3 | $5.47M | Sell |
127,172
-1,031
| -0.8% | -$45.7K | 0.71% | 35 |
|
|
2021
Q2 | $5.02M | Sell |
128,203
-1,651
| -1% | -$64.2K | 0.64% | 36 |
|
|
2021
Q1 | $4.7M | Buy |
129,854
+1,265
| +1% | +$44.9K | 0.62% | 36 |
|
|
2020
Q4 | $4.73M | Sell |
128,589
-7,401
| -5% | -$271K | 0.92% | 32 |
|
|
2020
Q3 | $4.74M | Sell |
135,990
-6,138
| -4% | -$215K | 1% | 30 |
|
|
2020
Q2 | $4.41M | Buy |
142,128
+344
| +0.2% | +$11.7K | 0.96% | 30 |
|
|
2020
Q1 | $4.39M | Buy |
141,784
+1,683
| +1% | +$57.3K | 1.04% | 23 |
|
|
2019
Q4 | $5.21M | Buy |
140,101
+1,343
| +1% | +$47.8K | 1.02% | 26 |
|
|
2019
Q3 | $4.73M | Buy |
138,758
+158
| +0.1% | +$5.75K | 0.98% | 24 |
|
|
2019
Q2 | $5.7M | Buy |
138,600
+1,732
| +1% | +$68.8K | 1.22% | 19 |
|
|
2019
Q1 | $5.51M | Buy |
136,868
+119
| +0.1% | +$4.77K | 1.28% | 17 |
|
|
2018
Q4 | $5.66M | Sell |
136,749
-314
| -0.2% | -$13K | 1.45% | 14 |
|
|
2018
Q3 | $5.73M | Buy |
137,063
+769
| +0.6% | +$29.6K | 1.2% | 17 |
|
|
2018
Q2 | $4.69M | Sell |
136,294
-6,099
| -4% | -$208K | 1.05% | 23 |
|
|
2018
Q1 | $4.79M | Sell |
142,393
-4,736
| -3% | -$163K | 1.11% | 20 |
|
|
2017
Q4 | $5.06M | Sell |
147,129
-12,295
| -8% | -$419K | 1.17% | 19 |
|
|
2017
Q3 | $5.4M | Buy |
159,424
+45
| +0% | +$1.45K | 1.28% | 17 |
|
|
2017
Q2 | $5.08M | Sell |
159,379
-3,130
| -2% | -$98.7K | 1.22% | 18 |
|
|
2017
Q1 | $5.27M | Buy |
162,509
+165
| +0.1% | +$5.2K | 1.29% | 17 |
|
|
2016
Q4 | $5M | Sell |
162,344
-1,998
| -1% | -$61K | 1.24% | 18 |
|
|
2016
Q3 | $5.28M | Sell |
164,342
-4,565
| -3% | -$153K | 1.34% | 16 |
|
|
2016
Q2 | $5.64M | Buy |
168,907
+288
| +0.2% | +$9.19K | 1.47% | 14 |
|
|
2016
Q1 | $4.74M | Sell |
168,619
-673
| -0.4% | -$19.2K | 1.26% | 20 |
|
|
2015
Q4 | $5.19M | Buy |
169,292
+10,985
| +7% | +$346K | 1.39% | 19 |
|
|
2015
Q3 | $4.72M | Buy |
158,307
+5,747
| +4% | +$184K | 1.34% | 20 |
|
|
2015
Q2 | $4.85M | Buy |
152,560
+13,554
| +10% | +$442K | 1.31% | 20 |
|
|
2015
Q1 | $4.59M | Buy |
139,006
+2,554
| +2% | +$81.2K | 1.23% | 20 |
|
|
2014
Q4 | $4.03M | Buy |
136,452
+6,767
| +5% | +$194K | 1.1% | 25 |
|
|
2014
Q3 | $3.64M | Buy |
129,685
+2,040
| +2% | +$57.3K | 1.01% | 22 |
|
|
2014
Q2 | $3.6M | Buy |
127,645
+1,581
| +1% | +$45.1K | 0.97% | 26 |
|
|
2014
Q1 | $3.84M | Buy |
126,064
+1,017
| +0.8% | +$30.3K | 1.09% | 19 |
|
|
2013
Q4 | $3.63M | Sell |
125,047
-8,279
| -6% | -$241K | 1.04% | 20 |
|
|
2013
Q3 | $3.63M | Sell |
133,326
-20,305
| -13% | -$552K | 1.12% | 20 |
|
|
2013
Q2 | $4.08M | Buy |
+153,631
| New | +$4.24M | 1.31% | 17 |
|
Other funds holding PFE
VCM
VPM
Arrow Financial's PFE Position: Q1 2026 in Review
Arrow Financial reduced its Pfizer (PFE) stake by 2.3% in Q1 2026, selling an estimated $7.19K and leaving 11,476 shares worth $322K. The position accounts for 0.03% of the portfolio, ranked #140.
Arrow Financial first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.38M in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Arrow Financial held 11,476 shares of Pfizer worth $322K as of Q1 2026.
- Arrow Financial sold 270 Pfizer shares in Q1 2026, an estimated $7.19K.
- Pfizer made up 0.03% of Arrow Financial's portfolio in Q1 2026, its #140 holding.
- Arrow Financial first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Arrow Financial's Pfizer position peaked at $7.38M in Q4 2021.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Arrow Financial's 13F filing for Q1 2026, filed 11 May 2026.